HighVista Strategies’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.39M Buy
179,256
+106,067
+145% +$4.14M 2.14% 8
2026
Q1
$2.59M Buy
73,189
+46,788
+177% +$1.45M 0.71% 47
2025
Q4
$739K Sell
26,401
-17,680
-40% -$530K 0.19% 125
2025
Q3
$1.32M Sell
44,081
-8,863
-17% -$250K 0.32% 100
2025
Q2
$1.51M Sell
52,944
-17,818
-25% -$530K 0.56% 63
2025
Q1
$2.34M Buy
70,762
+16,316
+30% +$532K 0.9% 24
2024
Q4
$1.57M Buy
+54,446
New +$1.57M 0.58% 61

Other funds holding ALKS

HighVista Strategies's ALKS Position: Q2 2026 in Review

HighVista Strategies increased its Alkermes (ALKS) stake by 145% in Q2 2026, buying an estimated $4.14M and bringing the position to 179,256 shares worth $9.39M. The position accounts for 2.14% of the portfolio, ranked #8.

HighVista Strategies first reported a position in ALKS in Q4 2024 and has held it in 7 quarters since. 425 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • HighVista Strategies held 179,256 shares of Alkermes worth $9.39M as of Q2 2026.
  • HighVista Strategies bought 106,067 Alkermes shares in Q2 2026, an estimated $4.14M.
  • Alkermes made up 2.14% of HighVista Strategies's portfolio in Q2 2026, its #8 holding.
  • HighVista Strategies first reported a position in Alkermes in Q4 2024 and has held it in 7 quarters since.
  • 425 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on HighVista Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.